Shares of Medicines Co. (MDCO) surged 34% in late trading after a U.S. District Court judge...

|About: The Medicines Company (MDCO)|By:, SA News Editor

Shares of Medicines Co. (MDCO) surged 34% in late trading after a U.S. District Court judge ruled the patent office should consider MDCO's Dec. 2000 patent extension application as timely. The decade-long saga centers on whether a patent filing for MDCO's blood-thinning drug Angiomax was mistakenly made one day late.